High Tower Advisors, LLC Gilead Sciences, Inc. Call Options Transaction History

High Tower Advisors, LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $315,750 - $364,400	5,000 Added 5000.0%	5,100 $349,000
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $7,158 - $8,729	100 New	100 $7,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $7,731 - $8,808	100 New	100 $8,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $5,714 - $6,435	99 Added 9900.0%	100 $1,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $5,734 - $7,185	-99 Reduced 99.0%	1 $0
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $4,062 - $4,438	-64 Reduced 39.02%	100 $1,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1.01 Million - $1.15 Million	-17,836 Reduced 99.09%	164 $53,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $1.06 Million - $1.33 Million	17,000 Added 1700.0%	18,000 $13,000
Q1 2020 May 21, 2020	SELL	$62.63 - $80.22 $62,630 - $80,220	-1,000 Reduced 50.0%	1,000 $8,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $866,180 - $971,319	-14,000 Reduced 87.5%	2,000 $3,000
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $997,920 - $1.1 Million	14,000 Added 700.0%	16,000 $46,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $473,460 - $577,200	-6,500 Reduced 76.47%	2,000 $1,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $476,705 - $559,584	-6,700 Reduced 44.08%	8,500 $2,000
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $93,743 - $111,111	-1,300 Reduced 7.88%	15,200 $72,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,500	16,500 $56,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.